Evidence map›Paper›PMID 34671535›Full record

ArticleCureus2021

Development of Lupus Erythematosus Tumidus During the Course of Systemic Sclerosis.

Constantine N Logothetis, Nikifor K Konstantinov, Michael D Reyes, N Suzanne Emil, Antonios H Tzamaloukas

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Constantine N LogothetisInternal Medicine, University of South Florida, Tampa, USA.
Nikifor K KonstantinovDermatology, University of Minnesota School of Medicine, Minneapolis, USA.
Michael D ReyesPathology, Raymond G. Murphy Veterans Affairs (VA) Hospital, Albuquerque, USA.
N Suzanne EmilInternal Medicine, University of New Mexico School of Medicine, Albuquerque, USA.
Antonios H TzamaloukasInternal Medicine, University of New Mexico School of Medicine, Albuquerque, USA.
Raymond G. Murphy VA Medical Center · USUniversity of New Mexico · USUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man with systemic sclerosis (SS), manifested by characteristic skin lesions, gastro-esophageal reflux disease, and pulmonary fibrosis producing progressive respiratory failure, and a positive antinuclear antibody consistent with reactivity to fibrillarin, developed skin lesions with the clinical and histological characteristics of lupus erythematosus tumidus (LET) 10 years after the diagnosis of SS. His respiratory failure progressed and he expired from sepsis after tracheal intubation and mechanical ventilation two years after developing LET. The association of SS and LET, not described until now, raises questions about its pathogenesis and its prognostic significance.

Indexed as

anti-nuclear antibodiescutaneous lupus erythematosusinterferon-mediated diseaselupus erythematosus tumidussystemic sclerosis

Identifiers

PMID34671535
PMCPMC8520756
OpenAlexW3200381559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.